CoChat

Melatonin enhances sorafenib actions in human hepatocarcinoma cells by inhibiting mTORC1/p70S6K/HIF-1α and hypoxia-mediated mitophagy

Open access
Prieto-Domínguez, Néstor, Méndez-Blanco, Carolina, Carbajo-Pescador, Sara, Fondevila, Flavia, García-Palomo, Andrés, González-Gallego, Javier, Mauriz, José L. · 2017 · Oncotarget
Cited by 75

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

// Néstor Prieto-Domínguez 1, 2, * , Carolina Méndez-Blanco 1, 2, * , Sara Carbajo-Pescador 1, 2 , Flavia Fondevila 1, 2 , Andrés García-Palomo 1, 3 , Javier González-Gallego 1, 2, ** and José L. Mauriz 1, 2, ** 1 Institute of Biomedicine (IBIOMED), University of León, León, Spain 2 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain 3 Service of Oncology, Complejo Asistencial Universitario de León, León, Spain * These authors have contributed equally to this work ** JLM and JGG share senior authorship Correspondence to: José L. Mauriz, email: jl.mauriz@unileon.es Keywords: hepatocarcinoma, hypoxia-inducible factor-1α, hypoxia-mediated mitophagy, melatonin, sorafenib Received: July 22, 2017 Accepted: August 09, 2017 Published: August 24, 2017 ABSTRACT The antiangiogenic effects of sustained sorafenib treatment in hepatocellular carcinoma (HCC) lead to the occurrence of hypoxia-mediated drug resistance resulting in low therapy efficiency and negative outcomes. Combined treatments with coadjuvant compounds to target the hypoxia-inducible factor-1α (HIF-1α) represent a promising therapeutic approach through which sorafenib efficiency may be improved. Melatonin is a well-documented oncostatic agent against different cancer types. Here, we evaluated whether melatonin could enhance sorafenib cytotoxicity and overcome the hypoxia-mediated resistance mechanisms in HCC. The pharmacological melatonin concentration (2 mM) potentiated the oncostatic effects of sorafenib (5 μM) on Hep3B cells even under hypoxia. Melatonin downregulated the HIF-1α protein synthesis through the inhibition of the mammalian target of rapamycin complex 1 (mTORC1)/ribosomal protein S6 kinase beta-1 (p70S6K)/ribosomal protein S6 (RP-S6) pathway, although the indole enhanced Akt phosphorylation by the mTORC1/C2 negative feedback. Furthermore, melatonin and sorafenib coadministration reduced the HIF-1α-mitophagy targets expression, impaired autophagosome formation and subsequent mitochondria and lysosomes colocalization. Together, our results indicate that melatonin improves the Hep3B sensitivity to sorafenib, preventing HIF-1α synthesis to block the cytoprotective mitophagy induced by the hypoxic microenvironment, an important element of the multifactorial mechanisms responsible for the chemotherapy failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.20592

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Prieto-Domínguez, N., Méndez-Blanco, C., Carbajo-Pescador, S., Fondevila, F., García-Palomo, A., González-Gallego, J., & Mauriz, J. L.
Venue
Oncotarget
Published
2017-08-24
Volume
8
Issue
53
Pages
91402-91414
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2753496952
Cited by
75
References
3
FWCI
5.70
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.